The Association of American Cancer Institutes is designing two programs to address systemic underrepresentation of racial and ethnic minority physicians and scientists in leadership positions in oncology.
The National Cancer Act of 1971 established an unprecedented government-wide plan to eradicate a major disease, creating institutions that have no equivalent in other therapeutic areas and galvanizing the nationwide conversation about cancer.
Prof. Elihu (Eli) H. Estey, MD, a pioneering AML researcher, physician and scholar collapsed and died unexpectedly on Oct. 8 at his home in Seattle. He was 75.
Our good friend and colleague Ed Gehan passed away on Sept. 28 at the age of 92. Ed and his contributions to cancer research and to cancer patients are legend.
A podcast on developments in genitourinary cancer is recording oral histories with pioneers of GU oncology. Sharpless discusses the history and future of NCI at the Paul Calabresi Memorial Lecture, Nov. 2.
Proton therapy is an ultra-precise form of radiation that spares patients excess radiation to the heathy tissues and organs surrounding their tumor.
Blanton S. Tolbert was named the first associate director for diversity, equity, and inclusion for the Case Comprehensive Cancer Center, complementing his recent appointment as vice dean for diversity, equity, and inclusive excellence for the Case Western Reserve School of Medicine.
The Case Comprehensive Cancer Center earned an additional $12 million from NCI as a two-year merit-based extension. The center was the first of two NCI-designated comprehensive cancer centers to be awarded this distinction, followed by Lurie Cancer Center.
Fidel A. Valea was appointed system chief of gynecologic oncology at Northwell Health and director of gynecologic oncology at the Northwell Health Cancer Institute. In these roles, he will see patients in New Hyde Park and Manhattan.
Stand Up To Cancer announced the Stand Up To Cancer–Fanconi Anemia Research Fund–Farrah Fawcett Foundation Head and Neck Cancer Research Team, which will focus on new approaches to address head and neck squamous cell carcinoma, with an emphasis on cancers related to the human papillomavirus and Fanconi anemia.
